Idiopathic Retroperitoneal Fibrosis
Open Access
- 9 February 2016
- journal article
- review article
- Published by Ovid Technologies (Wolters Kluwer Health) in Journal of the American Society of Nephrology
- Vol. 27 (7), 1880-1889
- https://doi.org/10.1681/asn.2015101110
Abstract
Idiopathic retroperitoneal fibrosis (RPF), reviewed herein, is a rare fibro-inflammatory disease that develops around the abdominal aorta and the iliac arteries, and spreads into the adjacent retroperitoneum, where it frequently causes ureteral obstruction and renal failure. The clinical phenotype of RPF is complex, because it can be associated with fibro-inflammatory disorders involving other organs, is considered part of the spectrum of IgG4-related disease, and often arises in patients with other autoimmune conditions. Obstructive uropathy is the most common complication, although other types of renal involvement may occur, including stenosis of the renal arteries and veins, renal atrophy, and different types of associated GN. Environmental and genetic factors contribute to disease susceptibility, whereas the immunopathogenesis of RPF is mediated by different immune cell types that eventually promote fibroblast activation. The diagnosis is made on the basis of computed tomography or magnetic resonance imaging, and positron emission tomography is a useful tool in disease staging and follow-up. Treatment of idiopathic RPF aims at relieving ureteral obstruction and inducing disease regression, and includes the use of glucocorticoids, combined or not with other traditional immunosuppressants. However, biologic therapies such as the B cell–depleting agent rituximab are emerging as potentially efficacious agents in difficult-to-treat cases.This publication has 82 references indexed in Scilit:
- Brief Report: Interleukin‐6 as an Inflammatory Mediator and Target of Therapy in Chronic PeriaortitisArthritis & Rheumatism, 2013
- Efficacy and complications of urinary drainage procedures in idiopathic retroperitoneal fibrosis complicated by extrinsic ureteral obstructionInternational Journal of Urology, 2013
- Methotrexate plus prednisone in patients with relapsing idiopathic retroperitoneal fibrosisAnnals Of The Rheumatic Diseases, 2013
- Localized Perirenal Retroperitoneal FibrosisUrology, 2013
- Malignant Retroperitoneal FibrosisMedicine, 2012
- IgG4-Related Disease Is Not Associated with Antibody to the Phospholipase A2 ReceptorInternational Journal of Rheumatology, 2012
- Cyclophosphamide is a highly effective and safe induction therapy in chronic periaortitis: a long-term follow-up of 35 patients with chronic periaortitisAnnals Of The Rheumatic Diseases, 2011
- Idiopathic Retroperitoneal Fibrosis: A Retrospective Review of Clinical Presentation, Treatment, and OutcomesMayo Clinic Proceedings, 2011
- Autoimmunity in Membranous Nephropathy Targets Aldose Reductase and SOD2Journal of the American Society of Nephrology, 2010
- The spectrum of chronic periaortitisHistopathology, 1990